Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era.

Humans Child Adolescent Young Adult Tyrosine Kinase Inhibitors Transplantation, Homologous Retrospective Studies Hematopoietic Stem Cell Transplantation Protein Kinase Inhibitors / therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy

Journal

American journal of hematology
ISSN: 1096-8652
Titre abrégé: Am J Hematol
Pays: United States
ID NLM: 7610369

Informations de publication

Date de publication:
08 2023
Historique:
revised: 23 04 2023
received: 28 03 2023
accepted: 30 04 2023
medline: 13 7 2023
pubmed: 12 5 2023
entrez: 12 5 2023
Statut: ppublish

Résumé

The analysis of 165 children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia showed disease status at hematopoietic stem cell transplantation was a strong prognostic factor and clearly separated the patient outcomes.

Identifiants

DOI: 10.1002/ajh.26959 PMID: 37170859
pubmed: 37170859
doi: 10.1002/ajh.26959
doi:

Substances chimiques

Tyrosine Kinase Inhibitors 0
Protein Kinase Inhibitors 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

E200-E203

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Hijiya N, Suttorp M. How I treat chronic myeloid leukemia in children and adolescents. Blood. 2019;133(22):2374-2384. doi:10.1182/blood.2018882233
Millot F, Maledon N, Guilhot J, Güneş AM, Kalwak K, Suttorp M. Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia. Eur J Cancer. 2019;115:17-23. doi:10.1016/j.ejca.2019.03.020
Shimada H, Tanizawa A, Kondo T, et al. Prognostic factors for outcomes of allogeneic HSCT for children and adolescents/young adults with CML in the TKI era. Transplant Cell Ther. 2022;28(7):376-389. doi:10.1016/j.jtct.2022.04.011
Chaudhury S, Sparapani R, Hu ZH, et al. Outcomes of allogeneic hematopoietic cell transplantation in children and young adults with chronic myeloid leukemia: a CIBMTR cohort analysis. Biol Blood Marrow Transplant. 2016;22(6):1056-1064. doi:10.1016/j.bbmt.2016.02.015
Niederwieser C, Morozova E, Zubarovskaya L, et al. Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML. Bone Marrow Transplant. 2021;56(11):2834-2841. doi:10.1038/s41409-021-01410-x
Jain P, Kantarjian HM, Ghorab A, et al. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: cohort study of 477 patients. Cancer. 2017;123(22):4391-4402. doi:10.1002/cncr.30864

Auteurs

Hisashi Ishida (H)

Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
ORCID: 0000-0002-3391-8403

Hiroyuki Shimada (H)

Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Akihiko Tanizawa (A)

Department of Pediatrics, Sugita Genpaku Memorial Obama Municipal Hospital, Obama, Japan.

Yutaka Shimazu (Y)

Department of Hematology Kyoto University Hospital, Kyoto, Japan.

Takayoshi Tachibana (T)

Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
ORCID: 0000-0002-7780-4459

Noriko Doki (N)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.

Takahide Ara (T)

Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Yayoi Matsuo (Y)

Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.

Miho Nara (M)

Division of Blood Transfusion, Akita University Hospital, Akita, Japan.

Tomomi Toubai (T)

Department of Hematology and Cell Therapy, Yamagata University Hospital, Yamagata, Japan.

Kazuko Ino (K)

Department of Hematology and Oncology, Mie University Hospital, Tsu, Japan.

Hirohisa Nakamae (H)

Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan.

Keisuke Kato (K)

Division of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Mito, Japan.

Koji Kato (K)

Central Japan Cord Blood Bank, Seto, Japan.

Atsushi Sato (A)

Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan.

Moeko Hino (M)

Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba, Japan.

Kimikazu Matsumoto (K)

Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

Yoshiko Atsuta (Y)

Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.

Masahiro Yasui (M)

Department of Pediatric Hematology/Oncology, Kitakyushu City Yahata Hospital, Kitakyushu, Japan.

Tokiko Nagamura-Inoue (T)

Department of Cell Processing and Transfusion, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Allogeneic stem cell transplantation for...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Allogeneic stem cell transplantation for...
questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Allogeneic stem cell transplantation for...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Allogeneic stem cell transplantation for...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation homologue › Allogeneic stem cell transplantation for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Allogeneic stem cell transplantation for...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches hématopoïétiques › Allogeneic stem cell transplantation for...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de protéines kinases › Allogeneic stem cell transplantation for...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Leucémie myéloïde chronique BCR-ABL positive › Allogeneic stem cell transplantation for...